Longevity is not a single outcome—it's a complex interplay of cardiovascular health, cognitive function, musculoskeletal integrity, immune resilience, and metabolic optimization. Rather than betting on a single compound, the most effective approach combines evidence-backed interventions that address multiple aging pathways simultaneously.
This article presents a tiered, strategic stack based on the strength of human evidence. By layering compounds with complementary mechanisms, you maximize synergistic effects while minimizing redundancy and cost. Whether you're building a foundation-level regimen or pursuing an advanced protocol, this guide maps the optimal combinations backed by randomized controlled trials, meta-analyses, and mechanistic research.
The philosophy: start with high-evidence foundations, then enhance with emerging compounds that target specific aging pathways relevant to your health goals.
Before diving into stack recommendations, it's critical to understand how compounds are ranked:
- Tier 4: Strong human evidence for specific outcomes (muscle, bone, skin, cognition) but limited direct proof of lifespan extension
- Tier 3: Probable efficacy for longevity-related outcomes; consistent mechanistic or intermediate-marker evidence, but limited long-term human data
- Tier 2-1: Theoretical or emerging compounds with minimal human evidence
The reality: No compound has definitively extended human lifespan in controlled trials. Instead, we stack compounds that improve healthspan markers—the biological and functional indicators most strongly associated with longevity.
These compounds have the strongest human evidence for improving outcomes relevant to aging and longevity. They're supported by large RCTs, multiple replications, and clinically meaningful effect sizes.
Role: Preserve and build lean muscle mass; support cognitive function in aging populations.
Evidence: In 12 RCTs involving 357 older adults, creatine combined with resistance training increased lean tissue mass with a p<0.0001 effect, and improved chest/leg press strength (p=0.004 and p=0.02 respectively). Muscle loss (sarcopenia) is one of the strongest predictors of mortality and frailty in aging—making muscle preservation a cornerstone of longevity strategy.
Why stack it: Creatine is synergistic with resistance training, which is itself one of the most evidence-backed longevity interventions. It's also water-soluble, affordable, and safe across decades of use.
Dosing: 3-5g once daily (no loading phase required, though some prefer 20g/day for 5-7 days followed by 3-5g daily)
Timing: Anytime; doesn't require fasting or coordination with meals. Consistent daily intake is key.
Cost: $8-$25/month
Role: Maintain skin health, support joint integrity, and preserve connective tissue function in aging.
Evidence: In a 114-woman RCT, 2.5g daily bioactive collagen peptides reduced skin wrinkles by 20% after 8 weeks, with improvements maintained 4 weeks post-supplementation. Procollagen type I increased 65% and elastin 18%—markers of structural skin integrity. While skin health appears cosmetic, it reflects deeper collagen remodeling relevant to vascular function, joint health, and connective tissue resilience throughout the body.
Why stack it: Collagen degradation is a hallmark of aging. By providing bioavailable peptides, you supply the building blocks for systemic collagen synthesis. Effects extend beyond skin to cartilage, tendons, and blood vessel walls.
Dosing: 10-20g once daily (bioactive peptides in the 2-5g range are most studied; higher doses are used for joint and gut health)
Timing: Morning or with a meal containing carbohydrates and protein; absorption is enhanced when paired with vitamin C.
Cost: $20-$60/month
Role: Preserve cognitive function and activities of daily living in aging populations.
Evidence: A meta-analysis of 9 RCTs (2,561 patients, 22-26 weeks duration) found that EGb 761 at 240 mg/day improved cognition versus placebo (weighted mean difference -2.86, p<0.001), improved activities of daily living (SMD -0.36), and improved global clinician impression (OR 1.88). While cognitive decline is not strictly a longevity marker, maintaining activities of daily living is critical for healthspan and independent aging.
Why stack it: Cognitive aging is one of the most feared aspects of growing older. Unlike many nootropics, ginkgo has replicated evidence in older populations and clinical dementia cohorts, not just healthy young subjects. It's neuroprotective via multiple mechanisms (antioxidant, anti-inflammatory, improved blood flow).
Dosing: 120-240mg twice daily (typically 120mg in AM, 120mg in PM for 240mg total daily dose)
Timing: With meals. The EGb 761 standardized extract (24% ginkgo flavone glycosides, 6% terpene lactones) is the most studied form.
Cost: $10-$35/month
Role: Reduce fracture risk and preserve bone mineral density in osteoporosis or high-risk populations.
Evidence: In the ACTIVE RCT (1,645 postmenopausal women, 18 months), abaloparatide reduced major osteoporotic fractures by 69% versus placebo and any clinical fracture by 43%. Fractures are a leading cause of morbidity and mortality in older adults; preventing them directly impacts longevity through reduced infection risk, hospitalization, and immobility-related complications.
Why stack it: If you have osteoporosis or osteopenia (identified via DEXA scan), fracture prevention is a high-impact longevity intervention. Abaloparatide is a peptide that stimulates bone-forming osteoblasts, distinctly different from bisphosphonates (which slow bone loss).
Dosing: 80 mcg once daily via subcutaneous injection (prefilled pen)
Timing: Any time of day; consistent daily administration is critical.
Cost: $1,800-$2,800/month (typically covered by insurance for documented osteoporosis)
Note: Requires prescription and medical supervision. Include only if you have bone density concerns identified by healthcare provider.
Once the foundation is solid, tier 3 compounds add targeted support for specific aging pathways. Choose 2-3 compounds based on your primary concerns (e.g., muscle loss, cognitive aging, metabolic health).
Role: Improve physical performance, muscle strength, cognitive function, and reduce inflammatory markers in aging.
Evidence: In a 50-person RCT of healthy athletes, VO2 max increased by 5.67 ml/kg/min with ashwagandha versus 1.86 ml/kg/min with placebo at 12 weeks (p<0.0001). Stress reduction (cortisol lowering) and anti-inflammatory effects support recovery from training and cognitive aging pathways.
Synergies: Pair with creatine + resistance training for amplified muscle and strength gains. Also synergistic with sleep optimization.
Dosing: 300-600mg once daily or split into two doses (typically as standardized extract containing 5% withanolides)
Timing: Morning or evening; take with food for better absorption.
Cost: $15-$45/month
Role: Support muscle mass, cardiovascular health, and cognitive function.
Evidence: In a 44-person RCT, fish oil increased thigh muscle volume by 3.6% and handgrip strength by 2.3 kg over 6 months in healthy older adults. Cardiovascular and anti-inflammatory benefits are well-established; cognitive protection is emerging.
Why it matters: EPA and DHA are structural components of cell membranes and critical for brain health. Unlike tier 4 compounds, omega-3 evidence for longevity is mixed—some studies show benefit, others don't—but the risk/benefit profile is strongly favorable.
Dosing: 1,000-4,000mg combined EPA+DHA once daily or split into two doses
Timing: With meals to improve absorption and reduce GI upset.
Cost: $10-$60/month
Role: Preserve telomere length, support mitochondrial function, reduce inflammation.
Evidence: In a 4,039-person observational study (US adults aged 45+), higher dietary magnesium intake was associated with longer leukocyte telomere length. The highest tertile (≥299 mg/day) versus lowest (<198 mg/day) showed 0.07 kb longer telomeres (p=0.038). While observational, this reflects magnesium's role in DNA repair and cellular stress resilience.
Synergies: Works synergistically with vitamin D and calcium for bone health; supports sleep quality when taken in evening.
Dosing: 200-400mg elemental magnesium once daily (bisglycinate or threonate forms are better absorbed and better tolerated than oxide)
Timing: Evening (supports sleep); separate from calcium and iron by 2+ hours.
Cost: $12-$45/month
Role: Support bone health, immune function, and reduce cellular aging markers.
Evidence: In the VITAL trial (1,054 participants), vitamin D3 at 2,000 IU/day reduced leukocyte telomere attrition by 0.14 kb over 4 years versus placebo (p=0.039). Telomere shortening is a marker of cellular aging; preserving telomere length correlates with longevity in observational studies.
Why it matters: Vitamin D deficiency is endemic in many populations, particularly in northern climates and among older adults with reduced sun exposure. Even modest supplementation shows measurable effects on aging biomarkers.
Dosing: 2,000-5,000 IU once daily (or 10,000 IU 2-3x weekly; serum 25(OH)D target is 40-60 ng/mL)
Timing: With breakfast or largest meal; fat-soluble vitamin requiring dietary fat for absorption.
Cost: $5-$20/month
Role: Reduce oxidative stress, improve vascular endothelial function, support cognitive aging.
Evidence: In a 39-person RCT, vascular endothelial function improved 37% following 12 weeks of 2,000 mg/day curcumin in healthy middle-aged/older adults. Mechanistically, curcumin suppresses NF-κB and inflammatory cytokines implicated in aging pathology.
Why it matters: Vascular function is a central predictor of longevity. Improving endothelial function (measured by flow-mediated dilation) correlates with better cardiovascular outcomes and reduced mortality risk.
Dosing: 500-1,000mg twice daily with black pepper (piperine) for enhanced bioavailability
Timing: With meals containing fat; piperine increases absorption 2,000-fold.
Cost: $10-$55/month
Role: Elevate NAD+ levels, support metabolic health, mitochondrial function, and muscle performance.
Evidence: In an 80-person RCT, blood NAD+ levels significantly increased in all NMN-treated groups (300, 600, 900 mg/day) at day 30 and 60 versus placebo (p≤0.001). NAD+ decline is a hallmark of aging; restoring it theoretically supports sirtuins, PARPs, and other longevity-related pathways.
Why it matters: This is one of the most mechanistically promising Tier 3 compounds, but human longevity data is absent. Consider it an emerging intervention with strong preclinical support.
Dosing: 250-500mg once daily
Timing: Morning, on empty stomach or with light meal.
Cost: $25-$80/month
Role: Support mitochondrial energy production and reduce age-related oxidative stress.
Evidence: A meta-analysis of 20 RCTs (n=2,617) found CoQ10 improved oocyte quality and embryo rates in women with ovarian aging—a marker of cellular vigor. CoQ10 is a critical component of the electron transport chain; levels decline with age.
Why it matters: While the oocyte evidence may seem narrow, it reflects CoQ10's fundamental role in cellular energy production. Ubiquinol (reduced form) is better absorbed than ubiquinone.
Dosing: 100-300mg once or twice daily (ubiquinol form preferred)
Timing: With meals containing fat; separate from statins by 2+ hours if on cholesterol medication.
Cost: $20-$75/month
Peptide compounds represent the frontier of longevity medicine. They're more expensive, require injection, and have less replicated human evidence than tier 4 compounds—but mechanistic evidence and preliminary human data suggest powerful effects.
Role: Support immune function and potentially reduce all-cause mortality in elderly populations.
Evidence: A single 6-8 year RCT in 266 elderly subjects found thymalin monotherapy reduced mortality 2.0-2.1-fold, with initial 2-3 years of treatment. This is the only Tier 3 peptide with direct mortality data, though it lacks independent replication.
Why it matters: Immune senescence (age-related immune decline) is a core driver of aging. Thymalin, derived from thymus extract, directly stimulates thymic function and T-cell production. The mortality signal, while from a single trial, is remarkable.
Dosing: 5-20mg once daily via subcutaneous injection
Timing: Any time; consistent daily administration.
Cost: $40-$120/month
Role: Protect and enhance cognitive function in mild-to-moderate cognitive decline and dementia.
Evidence: A meta-analysis of 6 human RCTs found cerebrolysin improved cognitive function (SMD -0.40, p=0.0031 at 4 weeks) and global clinical change, with 76% responder rate versus 57% placebo (p=0.007) in mild-to-moderate Alzheimer's disease.
Why it matters: Cerebrolysin is a standardized neuropeptide mixture with anti-inflammatory and neurotrophic properties. For those concerned about cognitive aging, it has the strongest peptide evidence.
Dosing: 5-30 mL (215-1,290mg peptide fraction) once daily for clinical courses; 3-5x per week for off-label cognitive use
Timing: Morning, via intramuscular or intravenous injection.
Cost: $80-$400/month (varies by treatment protocol)
Role: Restore growth hormone and IGF-I axis function in aging populations, supporting muscle, bone, and cognitive function.
Evidence: In a 32-person RCT, 25 mg/day MK-677 increased mean 24-hour GH concentration 97±23% in elderly subjects over 14 days. GH and IGF-I decline with age; restoring these hormones supports anabolic processes.
Why it matters: Unlike peptides that require injection, ibutamoren is oral, making it more convenient. However, evidence for actual longevity benefit is limited to 3 small RCTs.
Dosing: 10-25mg once daily
Timing: Evening (stimulates nighttime GH pulses); take on empty stomach for optimal effect.
Cost: $30-$80/month
Caution: Monitor for increased appetite, water retention, and carpal tunnel symptoms. Not ideal for those with sleep apnea (can worsen airway collapse).
Role: Improve metabolic health, reduce neurodegeneration risk, and potentially support longevity through multiple pathways.
Evidence: Epidemiological analysis in long-term GLP-1RA users shows reduced incidence of dementia, Parkinson disease,